Shaheen M Majeed

US Patent:

20200360448, Nov 19, 2020

Filed:

May 13, 2019

Appl. No.:

16/410054

Inventors:

Muhammed Majeed - Bangalore, IN
Kalyanam Nagabhushanam - East Windsor NJ, US
Furqan Ali - Bangalore, IN
Sivakumar Arumugam - Bangalore, IN
Shaheen Majeed - Springville UT, US
Kirankumar Beede - Bangalore, IN

International Classification:

A61K 35/742
C12N 5/00
A61P 3/10
A61P 29/00
A61P 1/16
C12N 1/20
A61K 9/19
A61K 9/48
A61K 9/20

Abstract:

The present invention discloses a novel fructophilic lactic acid producing bacteria strain FF-7 (MTCC 25235) and the process of isolation and characterization of the bacteria. The invention also discloses the biological applications/therapeutic use of fructophilic lactic acid producing bacteria in increased utilization of fructose from food stuff and in the managing disorders related to high fructose intake.

US Patent:

20200338139, Oct 29, 2020

Filed:

Dec 4, 2018

Appl. No.:

16/765372

Inventors:

Muhammed Majeed - Edison NJ, US
Kalyanam Nagabhushanam - East Windsor NJ, US
Anurag Pande - East Windsor NJ, US
Shaheen Majeed - Springville UT, US

Assignee:

SAMI LABS LIMITED - BANGALORE

International Classification:

A61K 35/742
A61K 36/45
A61K 9/00

Abstract:

The present invention discloses the microbial anti-adhesion effect of probiotic bacteria MTCC 5856. More specifically the invention discloses the ability of a composition containing probiotic bacteria MTCC 5856 in inhibiting the adhesion of harmful pathogenic microbes to the skin and mucosal surfaces thereby preventing the occurrence of an infection. Compositions containing probiotic bacteria MTCC 5856 along with plant/fruit extracts for use as an anti-adhesion agent are also disclosed.

US Patent:

20200316139, Oct 8, 2020

Filed:

Apr 2, 2019

Appl. No.:

16/372635

Inventors:

Muhammed Majeed - Bangalore, IN
Kalyanam Nagabhushanam - East Windsor NJ, US
Furqan Ali - Bangalore, IN
Sivakumar Arumugam - Bangalore, IN
Shaheen Majeed - Springville UT, US

International Classification:

A61K 35/742
A61P 1/00
A61K 9/00
A61K 9/48
A61K 38/43

Abstract:

The present invention discloses a stable probiotic composition comprising individually and/or in combination with multi-enzyme complex for the utilization of lactose and therapeutic management of lactose intolerance. It also discloses a method for the management of lactose intolerance using composition comprising individually and/or in combination with multi-enzyme complex.

US Patent:

20200316140, Oct 8, 2020

Filed:

Mar 31, 2020

Appl. No.:

16/836066

Inventors:

Muhammed Majeed - Bangalore, IN
Kalyanam Nagabhushanam - East Windsor NJ, US
Kirankumar Beede - Bangalore, IN
Sivakumar Arumugam - Bangalore, IN
Shaheen Majeed - Springville UT, US

International Classification:

A61K 35/742
A61K 38/46
A61K 38/47

Abstract:

The present invention discloses the potential of probiotic bacteria individually or in combination with multi-enzyme complex for reducing gluten content in foods rich in gluten and for the increased utilization of gluten. The invention further discloses a method for the management of gluten intolerance using composition comprising and multi-enzyme complex in mammals.

US Patent:

20200187519, Jun 18, 2020

Filed:

Feb 26, 2020

Appl. No.:

16/801250

Inventors:

Muhammed Majeed - Bangalore, IN
Kalyanam Nagabhushanam - East Windsor NJ, US
Sivakumar Arumugam - Bangalore, IN
Furqan Ali - Bangalore, IN
Shaheen Majeed - Springville UT, US

International Classification:

A23F 5/36
A23L 2/52
A23F 3/30
A61K 35/742

Abstract:

The present invention discloses beverage compositions comprising probiotic and water soluble prebiotic fibers that have been subjected to treatments under extreme stress, temperature and pressure conditions like brewing or aeration wherein the spore viability is maintained post said treatments.

US Patent:

20190328798, Oct 31, 2019

Filed:

Apr 29, 2019

Appl. No.:

16/396876

Inventors:

Muhammed Majeed - Bangalore, IN
Kalyanam Nagabhushanam - East Windsor NJ, US
Furqan Ali - Bangalore, IN
Sivakumar Arumugam - Bangalore, IN
Shaheen Majeed - Springville UT, US
Lakshmi Mundkur - Bangalore, IN
Anurag Pande - East Windsor NJ, US

International Classification:

A61K 35/742
C12N 1/20

Abstract:

The present invention discloses a composition comprising heat inactivated spores and/or comprising heat inactivated vegetative cells of probiotic bacteria , and a process for preparing the same. The invention also discloses a method of modulating immune function in mammals by activating macrophages, using a composition comprising in the form of live or heat inactivated spore and/or vegetative cells.

US Patent:

20190321308, Oct 24, 2019

Filed:

Apr 18, 2018

Appl. No.:

15/955905

Inventors:

Muhammed Majeed - Edison NJ, US
Kalyanam Nagabhushanam - East Windsor NJ, US
Shaheen Majeed - Springville UT, US

International Classification:

A61K 31/12
A61K 8/35
A61Q 11/00
A61K 9/20
A61P 1/02
A61K 9/48

Abstract:

Disclosed, is a novel composition containing tetrahydrocurcuminoids for the improvement of oral, health and hygiene. More specifically, disclosed is a novel composition of tetrahydrocurcuminoids and its application in the therapeutic management of canker sore and gingivitis.

US Patent:

20190290671, Sep 26, 2019

Filed:

Mar 22, 2019

Appl. No.:

16/361457

Inventors:

Muhammed Majeed - Edison NJ, US
Kalyanam Nagabhushanam - East Windsor NJ, US
Lakshmi Mundkur - Bangalore, IN
Shaheen Majeed - Springville UT, US
Anurag Pande - East Windsor NJ, US

International Classification:

A61K 31/7034
A61P 3/06
A61K 31/05

Abstract:

Disclosed are the hypolipidemic effects of a composition comprising at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin). The composition is effective in reducing the circulating levels of total cholesterol, triglycerides, LDL, cholesterol:HDL ratio and increasing HDL levels. The invention also discloses a method for reducing absorption and bio-accessibility of lipids in mammals using the abovementioned composition.